单机构直接置入乳房再造并发症预防与管理算法
该单机构回顾性研究纳入2014至2019年1027例单侧直接置入乳房再造患者,分析严重并发症与假体取出的危险因素。多因素分析显示较大假体尺寸、牛源补片、辅助放疗、低血浆白蛋白和高血糖与并发症显著相关;辅助放疗和肥胖与假体挽救率降低相关。手术部位感染和伤口裂开合并出现时假体取出风险增加超过14倍。
要点
- 较大假体尺寸、牛源补片、辅助放疗、低血浆白蛋白和高血糖与并发症显著相关。
- 辅助放疗(OR 7.44)和肥胖(OR 4.17)与假体挽救率显著降低相关。
- 手术部位感染合并伤口裂开时假体取出风险增加超过14倍(95%CI 9.97-19.53)。
核心结论
- 直接置入乳房再造的成功是多因素的,较大假体尺寸、辅助放疗、糖尿病和营养不良增加直接置入法并发症风险。
- 手术部位感染和伤口裂开应积极治疗,但两者合并出现提示挽救率差。
研究设计与样本
- 回顾性研究,纳入2014年至2019年所有接受单侧直接置入乳房再造的患者,共1027例。
- 采用多因素logistic回归模型和交互分析识别并发症和假体取出的危险因素。
主要发现
- 1027例患者中90例发生严重并发症,其中41例接受假体取出,49例成功挽救。
- 较大假体尺寸(p=0.003)、使用牛源补片(p<0.001)、辅助放疗(p=0.047)、低血浆白蛋白(p=0.013)和高血糖(p=0.006)与并发症显著相关。
- 辅助放疗(OR 7.44;95%CI 1.49-37.18;p=0.014)和肥胖(OR 4.17;95%CI 1.17-14.88;p=0.028)与假体挽救率显著降低及手术部位感染和伤口裂开相关。
- 保留乳头乳房切除术与保留皮肤乳房切除术在并发症率和取出率上无差异。
- 手术部位感染和伤口裂开合并出现时假体取出风险增加超过14倍(95%CI 9.97-19.53)。
关键数值与推荐
- 辅助放疗与假体挽救率降低相关(OR 7.44;95%CI 1.49-37.18;p=0.014)。
- 肥胖与假体挽救率降低相关(OR 4.17;95%CI 1.17-14.88;p=0.028)。
- 手术部位感染和伤口裂开合并时假体取出风险增加超过14倍(95%CI 9.97-19.53)。
临床怎么用
- 手术部位感染和伤口裂开应积极治疗,但两者合并出现提示挽救率差。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Complications including infection and wound dehiscence are major concerns for direct-to-implant breast reconstruction. However, the risk factors associated with severe complications and implant salvage remain unclear. METHODS: This was a retrospective study of all patients undergoing unilateral direct-to-implant breast reconstruction from 2014 through 2019. The risk factors associated with complications and prosthesis explantation were identified using multivariate logistic regression modeling and interaction analyses. RESULTS: Among 1027 patients enrolled, 90 experienced severe complications, 41 of whom underwent prosthesis explantation; 49 were successfully salvaged. Multivariate analysis demonstrated that patients with larger implant size ( p = 0.003), use of bovine mesh ( p < 0.001), adjuvant radiotherapy ( p = 0.047), low plasma albumin ( p = 0.013), and elevated blood glucose ( p = 0.006) were significantly more likely to have complications. Adjuvant radiation therapy (OR, 7.44; 95 percent CI, 1.49 to 37.18; p = 0.014) and obesity (OR, 4.17; 95 percent CI, 1.17 to 14.88; p = 0.028) were associated with significantly lower rates of implant salvage and surgical-site infection and wound dehiscence, whereas mastectomy skin flap necrosis was not associated with device explantation. There were no differences in complication and explantation rates between nipple-sparing and skin-sparing mastectomies. However, the combined impact of surgical-site infection and wound dehiscence added a greater than 14-fold higher risk of prosthesis explantation (95 percent CI, 9.97 to 19.53). CONCLUSIONS: Success in direct-to-implant breast reconstruction is multifactorial. Larger implant size, adjuvant radiation therapy, diabetes, and malnutrition demonstrate increased risk of complications in the direct-to-implant approach. Surgical-site infections and wound dehiscence should be treated aggressively, but the combination of both complications portends poor salvage rates. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.
引用
- Yin Z, Wang H, Liu Y, et al. Single-Institution Algorithm for Prevention and Management of Complications in Direct-to-Implant Breast Reconstruction. Plast Reconstr Surg. 2022. PMID: 35943963. doi:10.1097/PRS.0000000000009490
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。